Distinct recurrence patterns according to disease manifestation in pilonidal sinus disease treated with cleft lift surgery at 5 years’ follow‐up in a large prospective Danish cohort
Colorectal Disease · 2025
DOI: 10.1111/codi.17238 ↗Kurz gefasst
Fachartikel in der Zeitschrift Colorectal Disease, 2025. Verfasst von Natashja Pedersen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Pilonidal Disease Center, Department of Surgery, Randers Regional Hospital, Randers, Denmark. Hauptthemen laut MEDLINE: Pilonidal Sinus, Recurrence. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 16 Literaturangaben.
Abstract (Originalsprache)
Aim
Pilonidal sinus disease (PSD) is a common condition particularly affecting the young population. The disease is incompletely understood, and optimal treatment is still debated. However, off‐midline closure techniques have become the standard of care in more advanced cases. The literature is, however, lacking disease stratification in evaluation of surgical results. The aim of this study was to evaluate the surgical outcomes in a prospective cohort following Bascom's cleft lift (BCL) in primary extensive disease, nonhealing wounds after previous surgery and recurrence on a large Danish cohort from a high‐volume centre.
Method
The study is based on a prospective database established at Randers Regional Hospital in 2016. All patients undergoing BCL surgery from June 2016 until June 2020 were included in this study.
Results
Three hundred and ninety two patients (326 men/66 women) underwent BCL surgery over a 4‐year period. Of these, 127 (32.4%) presented with primary extensive PSD, 136 (34.7%) with nonhealing wounds and 129 (33.9%) with recurrent PSD. Overall, 87% healed uneventfully within the first 3 months, and 17% had recurrence at a median follow‐up of 60 months (45–73 months). However, the risk of recurrence was higher among patients with nonhealing wounds (20%) and recurrence (17%) compared with primary extensive manifestation (13%).
Conclusion
Treatment of advanced PSD remains challenging with a high rate of wound complications and recurrences, stressing the need for dedicated care. Patients with either failed surgery or recurrence need particular attention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Pilonidal Disease Center, Department of Surgery, Randers Regional Hospital, Randers, Denmark.
- Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark.
- Department of Clinical Medicine, Aarhus University Hospital and Aarhus University, Aarhus, Denmark.
- Nordsim, Aalborg University Hospital, Aalborg, Denmark.
- Department of Procto-Surgery and Pilonidal Sinus, St Marienhospital Vechta, Academic Teaching Hospital of the MHH Hannover, Vechta, Germany.
- Chirurgische Klinik, Universitätsklinik Um Bonn, Bonn, Germany.
ORCID-Profile: Susanne Haas
Zitieren
APA
Pedersen, N., Faurschou, I. K., Ankersen, J. L., Sørensen, M. J., Friis, M. L., Pedersen, A. G., Doll, D., & Haas, S. (2025). Distinct recurrence patterns according to disease manifestation in pilonidal sinus disease treated with cleft lift surgery at 5 years’ follow‐up in a large prospective Danish cohort. Colorectal Disease. https://doi.org/10.1111/codi.17238
Vancouver
Pedersen N, Faurschou IK, Ankersen JL, Sørensen MJ, Friis ML, Pedersen AG, et al. Distinct recurrence patterns according to disease manifestation in pilonidal sinus disease treated with cleft lift surgery at 5 years’ follow‐up in a large prospective Danish cohort. Colorectal Disease. 2025. doi:10.1111/codi.17238
BibTeX
@article{Pedersen2025,
author = {Pedersen, Natashja and Faurschou, Ida Kaad and Ankersen, Julie Lykke and Sørensen, Marlene Julia and Friis, Mikkel Lønborg and Pedersen, Allan Gorm and Doll, Dietrich and Haas, Susanne},
title = {Distinct recurrence patterns according to disease manifestation in pilonidal sinus disease treated with cleft lift surgery at 5 years’ follow‐up in a large prospective Danish cohort},
journal = {Colorectal Disease},
year = {2025},
doi = {10.1111/codi.17238}
}
EUVIMED